Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.74
Delayed Data
As of Feb 17
 -0.03 / -1.69%
Today’s Change
1.39
Today|||52-Week Range
2.85
+18.77%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.77
Today’s open1.75
Day’s range1.70 - 1.77
Volume7,818
Average volume (3 months)28,155
Market cap$29.9M
Dividend yield--
Data as of 3:57pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)-66.37%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
MSTXMast Therapeutics In...+0.00+0.70%
OGENOragenics Inc-0.01-1.56%
RPRXRepros Therapeutics ...+0.03+2.52%
MRNSMarinus Pharmaceutic...0.000.00%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts


Search for Jobs